⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PRME News
Prime Medicine, Inc. Common Stock
Prime Medicine Announces First Patient Dosed in Global Phase 1/2 Clinical Trial of PM577a for H1069Q-Mutated Wilson Disease
globenewswire.com
PRME
Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM647 in Alpha-1 Antitrypsin Deficiency
globenewswire.com
PRME
In Vivo Gene Editing Market Size, Share & Trends Analysis - Global Opportunity Analysis & Industry Forecast (2026-2036)
globenewswire.com
CRSP
NTLA
EDIT
BEAM
PRME
SANG
CRBU
REGN
Prime Medicine to Participate in Upcoming Investor Conferences
globenewswire.com
PRME
Form 8-K
sec.gov
PRME
Prime Medicine Reports Second Quarter 2026 Financial Results and Provides Business Updates
globenewswire.com
PRME
Prime Medicine Reports Second Quarter 2026 Financial Results and Provides Business Updates
globenewswire.com
PRME
Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM577a in H1069Q-mutated Wilson Disease
globenewswire.com
PRME
Form 8-K
sec.gov
PRME
Prime Medicine Announces Positive Resolution to Arbitration with Beam Therapeutics
globenewswire.com
PRME